Human pluripotent stem cells (PSCs) represent an attractive source of cardiomyocytes with
potential applications including disease modeling, drug discovery and safety screening, and …

The promise of human embryonic stem cell (hESC) lines for treating injuries and
degenerative diseases, for understanding early human development, for disease modelling …

Human embryonic stem cells (hESCs) are pluripotent cells that have the potential to
differentiate into any tissue in the human body; therefore, they are a valuable resource for …

The ability of pluripotent stem cells to self-renew and differentiate into all somatic cell types
brings great prospects to regenerative medicine and human health. However, before clinical …

The field of stem cell therapeutics is moving ever closer to widespread application in the
clinic. However, despite the undoubted potential held by these therapies, the balance …

The versatility of pluripotent stem cells, attributable to their unlimited self-renewal capacity
and plasticity, has sparked a considerable interest for potential application in regenerative …

Embryonic stem cells (ESCs) provide hope as a potential regenerative therapy for
neurological conditions such as Parkinson's disease and spinal cord injury. Currently, ESC …

Induced pluripotent stem cells (iPSCs) with potential for therapeutic applications can be
derived from somatic cells via ectopic expression of a set of limited and defined transcription …

Human embryonic stem cells (hESC) have emerged as attractive candidates for cell-based
therapies that are capable of restoring lost cell and tissue function. These unique cells are …

Replacing defective retinal pigment epithelial (RPE) cells with those derived from human
embryonic stem cells (hESCs) or human-induced pluripotent stem cells (hiPSCs) is a …